News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Psyadon Pharmaceuticals, Inc. Announces Dr. William Nyhan’s Participation in the Clinical Trial of Ecopipam in Lesch-Nyhan Disease



6/9/2010 9:51:12 AM

GERMANTOWN, Md.--(BUSINESS WIRE)--Psyadon Pharmaceuticals, Inc. announces today the opening of a clinical research site at the University of California at San Diego headed by Dr. William Nyhan. He joins Dr. Hyder Jinnah at Emory University to study the safety and tolerability of different doses of ecopipam in adults (group 1), adolescents (group 2) and children (group 3) with Lesch-Nyhan Disease (LND).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES